Acute myeloid leukemia

Acute myeloid leukemia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Acute myeloid leukemia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardigram

Chest X Ray

Echocardiograph and Ultrasound

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Acute myeloid leukemia On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Acute myeloid leukemia

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Acute myeloid leukemia

CDC on Acute myeloid leukemia

Acute myeloid leukemia in the news

Blogs on Acute myeloid leukemia

Directions to Hospitals Treating Acute myeloid leukemia

Risk calculators and risk factors for Acute myeloid leukemia

For patient information click here

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:  Raviteja Guddeti, M.B.B.S. [2] Carlos A Lopez, M.D. [3] Shyam Patel [4]; Grammar Reviewer: Natalie Harpenau, B.S.[5]

Synonyms and keywords: AML; acute granulocytic leukaemia; acute myeloblastic leukemia; acute myelogenous leukemia; acute nonlymphocytic leukemia; M7; megakaryocytic leukemia; Acute monocytic leukemia; AMoL; AML-M5

## Overview

[edit | edit source]

## Historical Perspective

[edit | edit source]

## Classification

[edit | edit source]

## Pathophysiology

[edit | edit source]

## Causes

[edit | edit source]

## Differentiating Acute Myeloid Leukemia from Other Diseases

[edit | edit source]

## Epidemiology and Demographics

[edit | edit source]

## Risk Factors

[edit | edit source]

## Screening

[edit | edit source]

## Natural History, Complications and Prognosis

[edit | edit source]

## Diagnosis

[edit | edit source]

Diagnostic Study of Choice | History and Symptoms | Physical Examination | Laboratory Findings | Electrocardigram | Chest X Ray | Echocardiograph and Ultrasound | CT | MRI | Other Imaging Findings | Other Diagnostic Studies

## Treatment

[edit | edit source]

Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies

## Case Studies

[edit | edit source]

Case #1

## Related Chapters

[edit | edit source]

* Chloroma
* Chronic myelogenous leukemia
* Acute lymphoblastic leukemia

## External links

[edit | edit source]

* National Cancer Institute (NCI) PDQ statement on AML for health professionals

Template:Blood

* v
* t
* e

Myeloid Hematological malignancy/leukemia histology (ICD-O 9590-9989, C81-C96, 200-208)

CFU-GM/
and other granulocytes|

Template:Navbox subgroup

MEP|

Template:Navbox subgroup

CFU-Mast|

Mastocytoma (Mast cell leukemia, Mast cell sarcoma, Systemic mastocytosis)

Multiple/unknown|

AML (Acute panmyelosis with myelofibrosis, Myeloid sarcoma) * MP (Myelofibrosis) * Acute biphenotypic leukaemia

See also hematology, lymphoid malignancy

Template:WikiDoc Sources
*[v]: View this template
*[t]: Discuss this template
*[e]: Edit this template